Jamie L. Reynoso
Chief Executive Officer of Medicare Advantage
CEO
COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $550,001 | $1,468,166 |
| 2024 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $550,000 | $4,792,147 |
| 2023 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $486,539 | $2,494,844 |
| 2022 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $440,385 | $2,929,875 |
| 2021 | Clover Health Investments, Corp. /De (CLOV) | Chief Executive Officer of Medicare Advantage | $411,539 | $3,048,484 |
Executive changes
-
Appointed Chief Executive Officer of Medicare Advantage at Clover Health Investments, Corp. /De (CLOV)2023-01-06
Earnings-call appearances
No earnings-call appearances recorded yet.